General Hospital of Athens Sismanoglio Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2020
NCT04344951
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

General Hospital of Athens Sismanoglio | General Hospital of Athens "Sismanoglio", 2nd Department of Pathology

Active Ingredients

Drugs in Phase 2 Trials (1)

chloroquine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pneumonia (Phase 2)

Pneumonia, Viral (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1